1389323-51-6 Usage
Description
1-(Oxetan-3-yl)-1H-pyrazole-4-carboxylic acid is a heterocyclic chemical compound with the molecular formula C8H8N2O3. It features a pyrazole ring fused with a carboxylic acid group and an oxetanyl cyclic ether attached to the pyrazole ring. 1-(Oxetan-3-yl)-1H-pyrazole-4-carboxylic acid serves as a potential intermediate in the synthesis of pharmaceuticals and organic compounds, offering unique structural and property advantages for research and development in medicinal chemistry and organic synthesis.
Uses
Used in Pharmaceutical Industry:
1-(Oxetan-3-yl)-1H-pyrazole-4-carboxylic acid is used as a potential intermediate for the synthesis of new drugs, leveraging its unique structure to contribute to the development of innovative pharmaceuticals.
Used in Organic Synthesis:
In the field of organic synthesis, 1-(Oxetan-3-yl)-1H-pyrazole-4-carboxylic acid is utilized as a building block, enabling the creation of a variety of complex organic compounds for diverse applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1389323-51-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,8,9,3,2 and 3 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1389323-51:
(9*1)+(8*3)+(7*8)+(6*9)+(5*3)+(4*2)+(3*3)+(2*5)+(1*1)=186
186 % 10 = 6
So 1389323-51-6 is a valid CAS Registry Number.
1389323-51-6Relevant articles and documents
METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION
-
Paragraph 0778-0779, (2021/11/20)
Mutations in oncogenes and tumor suppressors contribute to the development and progression of cancer. The present disclosure describes compounds and methods to recover wild-type function to p53 mutants. The compounds of the present disclosure can bind to mutant p53 and restore the ability of the p53 mutant to bind DNA and activate downstream effectors involved in tumor suppression. The disclosed compounds can be used to reduce the progression of cancers that contain a p53 mutation.
Positive allosteric modulators of nicotinic acetylcholine receptor
-
Page/Page column 32, (2012/10/08)
The present invention relates to compounds useful in therapy, to compositions comprising said compounds, and to methods of treating diseases comprising administration of said compounds. The compounds referred to are positive allosteric modulators (PAMs) of the nicotinic acetylcholine α7 receptor.
